Brain Cancer Clinical Trials

Showing 561-580 of 1,466 trials

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

NCT02101905

This pilot phase I clinical trial studies how well lapatinib ditosylate before surgery works in treating patients with high-grade glioma that has come back after a period of time during which the tumor could not be detected. Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Oligodendroglioma+4 more

National Cancer Institute (NCI)29 participantsStarted Nov 2016

Los Angeles, California, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +9 more locations

Approved For Marketing

Vorasidenib Expanded Access Program

NCT05592743

This is an expanded access program to provide vorasidenib for treatment of patients 12 years or older with IDH1- or IDH2-mutated glioma.

GliomaRecurrenceDisease Attributes+8 more

Servier

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Vorasidenib Expanded Access Program

Related Searches

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

Brain Areas of Time-To-Contact Perception: an Awake Surgery Study

Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy

Assessment of Cognitive Functions in Patients Receiving Whole Brain Radiotherapy in Assiut University Hospitals.

Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma

Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas

StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord

Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma Multiforme

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

TVI-Brain-1 in Expanded Access Patient

Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas

The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM

Monitoring of Patients With Low-grade Gliomas Using Circulating miRNA

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG